Statewide

Massachusetts Office of Emergency Medical Services

Current195 dose entries49 drugs12 documentsMAeffective 2026-09-0196% machine-parsed of 195

Massachusetts Office of Emergency Medical Services (MA) carries 49 drugs across 195 dose entries in its current published protocol, effective 2026-09-01.

Drugs and doses49

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	650–1000 mg	PO	not captured	standing	page 37
Mild to moderate pain	adult	650–1000 mg	IV	not captured	standing	page 37
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	page 37
Mild to moderate pain	peds	15 mg/kg	IV	not captured	standing	page 37

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV/IO	not captured	standing	pages 66, 67
SVT	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 66, 67
Wide-complex tachycardia	adult	6 mg	IV	not captured	standing	page 68

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2.5 mg	NEB	not captured	standing	pages 16, 17
Anaphylaxis	peds	1.25 mg	NEB	not captured	standing	pages 16, 17
Asthma / bronchospasm	adult	2.5–3 mg	NEB	not captured	standing	pages 23, 25
Asthma / bronchospasm	peds	1.25 mg	NEB	not captured	standing	pages 23, 25
Other	adult	2.5–3 mg	NEB	not captured	standing	page 38

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	150 mg	IV/IO	not captured	standing	page 56
Cardiac arrest	adult	300 mg	IV/IO	not captured	standing	pages 61, 62
Cardiac arrest	peds	5 mg/kg	IV/IO	not captured	standing	pages 61, 62
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	page 68
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	page 68

Amyl Nitrite

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	2 inhalants	NEB	not captured	standing	page 38
Cyanide poisoning	peds	2 inhalants	NEB	not captured	standing	page 38

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324–325 mg	PO	not captured	standing	pages 53, 162

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	pages 57, 58
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 57, 58
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 59, 60
Cardiac arrest	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 59, 60
Nerve agent exposure	adult	2 mg	IV/IO	not captured	standing	page 29
Other	adult	2–5 mg	IV/IO	not captured	standing	page 38
Other	peds	0.02 mg/kg	IV/IO	not captured	standing	page 38

Buprenorphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	16 mg	SL	not captured	standing	page 105

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV	not captured	standing	page 49
Hyperkalemia	peds	20 mg/kg	IV	not captured	standing	page 49
Other	adult	1 g	IV/IO	not captured	standing	page 57
Other	adult	1 g	IV/IO	not captured	standing	page 59
Other	adult	1 g	IV/IO	not captured	standing	page 38
Other	adult	1 g	IV/IO	not captured	standing	page 32
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 57
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 59
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 38
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 32

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV	not captured	standing	page 49
Hyperkalemia	peds	20 mg/kg	IV	not captured	standing	page 49
Other	adult	1 g	IV/IO	not captured	standing	page 57
Other	adult	1 g	IV/IO	not captured	standing	page 59
Other	adult	1 g	IV/IO	not captured	standing	page 32
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 57
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 59
Other	peds	20 mg/kg	IV/IO	not captured	standing	page 32

Cetirizine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	10 mg	PO/ODT	not captured	standing	pages 16, 17
Anaphylaxis	adult	10 mg	IV	not captured	standing	pages 16, 17
Anaphylaxis	peds	2.5 mg	PO/ODT	not captured	standing	pages 16, 17
Anaphylaxis	peds	2.5 mg	IV	not captured	standing	pages 16, 17

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	peds	0.5 g/kg	IV/IO	not captured	standing	page 142
Hypoglycemia	adult	12.5 g	IV/IO	not captured	standing	pages 18, 19
Hypoglycemia	peds	0.5 g/kg	IV/IO	not captured	standing	pages 18, 19

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	IM	not captured	standing	page 29

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	0.25 mg/kg	IV/IO	not captured	standing	page 56
SVT	adult	0.25 mg/kg	IV/IO	not captured	standing	page 66

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	50 mg	IV	not captured	standing	page 158

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 16
Bradycardia	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 57
Hypotension / shock	adult	2–20 mcg/kg	IV/IO	not captured	standing	pages 42, 44
Hypotension / shock	peds	2–20 mcg/kg	IV/IO	not captured	standing	pages 42, 44
Other	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 79
Sepsis	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 45

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 16, 17
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 16, 17
Asthma / bronchospasm	adult	0.1–0.5 mg	IV/IO	not captured	standing	page 23
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	pages 23, 25
Asthma / bronchospasm	peds	0.15 mg	IM	not captured	standing	pages 23, 25
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	pages 57, 58
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	page 58
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 59, 60, 61, 62
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 59, 60, 61, 62
Sepsis	peds	0.1–1 mcg/kg	IV/IO	not captured	standing	pages 45, 46

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5–1 mcg/kg	IV/IO	not captured	standing	page 89
Mild to moderate pain	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 37
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 37
Procedural sedation	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 124
Procedural sedation	adult	50–100 mcg	IV/IO/IM/IN	not captured	standing	page 145
Procedural sedation	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 145

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	20–40 mg	IV/IO	not captured	standing	page 63
Hyperkalemia	adult	0.5–1 mg/kg	IV/IO	not captured	standing	page 142
Hyperkalemia	peds	0.5–1 mg/kg	IV/IO	not captured	standing	page 142
Other	adult	40 mg	IV/IO	not captured	standing	page 38
Other	peds	0.5 mg/kg	IV/IO	not captured	standing	page 38

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1–5 mg	IV/IO/IM	not captured	standing	page 38
Beta-blocker / calcium-channel-blocker overdose	peds	0.5 or 1 mg	IV/IO/IM	not captured	standing	page 38
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	pages 18, 19, 96
Hypoglycemia	adult	1 mg	IV/IO	not captured	standing	pages 18, 19
Hypoglycemia	peds	0.1 mg/kg (max 1 mg)	IV/IO	not captured	standing	pages 18, 19
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	pages 18, 19, 96
Other	adult	1–5 mg	IV/IO/IM	not captured	standing	page 38
Other	peds	0.5 or 1 mg	IV/IO/IM	not captured	standing	page 38

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	page 21

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IO/IM	not captured	standing	page 15
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 15
Anaphylaxis	adult	100 mg	IV/IO/IM	not captured	standing	pages 16, 17
Anaphylaxis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 16, 17
Asthma / bronchospasm	adult	100 mg	IV/IO/IM	not captured	standing	pages 23, 26
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 23, 26

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	page 38
Cyanide poisoning	peds	70 mg/kg	IV/IO	not captured	standing	page 38

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	600 mg	PO	not captured	standing	page 37
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	page 37

Insulin

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	10 unit	IV/IO	not captured	standing	page 142
Hyperkalemia	peds	0.1 unit/kg	IV/IO	not captured	standing	page 142

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	pages 23, 25
Asthma / bronchospasm	peds	250 mcg	NEB	not captured	standing	pages 23, 25

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	4 mg/kg	IM	not captured	standing	page 21
Mild to moderate pain	adult	0.15 mg/kg	IV/IO	not captured	standing	page 37
Mild to moderate pain	adult	0.3 mg/kg	IM/IN	not captured	standing	page 37
Procedural sedation	adult	1 mg/kg	IM	not captured	standing	page 124
Procedural sedation	adult	50 mg	IM	not captured	standing	page 145

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 37
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 37
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	page 37
Mild to moderate pain	peds	0.5 mg/kg	IM	not captured	standing	page 37

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	40 mg	IO	not captured	standing	page 7
Mild to moderate pain	peds	1 mg/kg	IO	not captured	standing	page 7
VF / pulseless VT	adult	1.5 mg/kg	IV/IO	not captured	standing	page 61

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2–4 g	IV/IO	not captured	standing	pages 23, 26
Asthma / bronchospasm	peds	25 mg/kg	IV/IO	not captured	standing	pages 23, 26
Crush injury	adult	2–4 g	IV/IO	not captured	standing	page 78
Other	adult	2–4 g	IV/IO	not captured	standing	pages 32, 39
Wide-complex tachycardia	adult	2–4 g	IV/IO	not captured	standing	pages 61, 68

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	page 15
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 15
Anaphylaxis	adult	125 mg	IV/IO/IM	not captured	standing	pages 16, 17
Anaphylaxis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 16, 17
Asthma / bronchospasm	adult	125 mg	IV/IO/IM	not captured	standing	pages 23, 26
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 23, 26

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	2.5–5 mg	IV/IO	not captured	standing	page 56
Other	adult	5 mg	IV	not captured	standing	page 157

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10 mg	IN	not captured	standing	page 21
Agitation	adult	5 mg	IV/IO/IM	not captured	standing	page 21
Agitation	peds	0.1 mg/kg (max 6 mg)	IV/IO/IM	not captured	standing	page 21
Agitation	peds	0.1 mg/kg (max 6 mg)	IN	not captured	standing	page 21
Nerve agent exposure	adult	10 mg	IN	not captured	standing	pages 29, 31
Nerve agent exposure	adult	5 mg	IV/IO/IM	not captured	standing	pages 29, 31
Nerve agent exposure	peds	See pediatric dosing table	IV/IO/IM	not captured	standing	pages 29, 31
Nerve agent exposure	peds	See pediatric dosing table	IN	not captured	standing	pages 29, 31
Other	adult	0.05 mg/kg (max 5 mg)	IV/IO	not captured	standing	page 89
Other	adult	2–6 mg	IV/IO/IM	not captured	standing	page 32
Other	adult	2–6 mg	IN	not captured	standing	page 32
Other	adult	2–6 mg	IV/IO/IM/IN	not captured	standing	page 38
Other	peds	0.05 mg/kg	IV/IO/IM/IN	not captured	standing	page 38
Procedural sedation	adult	2–10 mg	IN	not captured	standing	page 124
Procedural sedation	peds	0.05 mg/kg	IV/IO/IM	not captured	standing	page 124
Procedural sedation	peds	0.05 mg/kg	IN	not captured	standing	page 124
Seizure	adult	10 mg	IN	not captured	standing	pages 39, 40
Seizure	adult	5 mg	IV/IO/IM	not captured	standing	pages 39, 40
Seizure	peds	0.1 mg/kg (max 8 mg)	IV/IO/IM	not captured	standing	pages 39, 40
Seizure	peds	0.2 mg/kg (max 10 mg)	IN	not captured	standing	pages 39, 40

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.1 mg/kg	IV/IO/IM	not captured	standing	page 37
Mild to moderate pain	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 37
Procedural sedation	adult	0.1 mg/kg	IV/IO/IM/SQ	not captured	standing	page 124

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4 mg	IM/IN	not captured	standing	page 38
Opioid overdose	peds	0.1 mg/kg	IM/IN	not captured	standing	page 38

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 53, 162
CHF / pulmonary edema	adult	0.4–0.8 mg	SL	not captured	standing	page 63
CHF / pulmonary edema	adult	1 inch	TOP	not captured	standing	page 63

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.1–0.5 mcg/kg	IV/IO	not captured	standing	page 16
Hypotension / shock	adult	0.1–0.5 mcg/kg	IV/IO	not captured	standing	pages 42, 44
Other	adult	0.1–0.5 mcg/kg	IV/IO	not captured	standing	page 79
Sepsis	adult	0.1–0.5 mcg/kg	IV/IO	not captured	standing	pages 45, 46
Sepsis	peds	0.1–0.5 mcg/kg	IV/IO	not captured	standing	pages 45, 46

Olanzapine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10 mg	PO/ODT	not captured	standing	pages 21, 103

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	PO/ODT	not captured	standing	page 37
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	page 37
Nausea / vomiting	peds	2 mg	PO/ODT	not captured	standing	page 37
Nausea / vomiting	peds	2 mg	IV/IM	not captured	standing	page 37

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 tube	PO	not captured	standing	pages 18, 19
Hypoglycemia	peds	0.5 tube (<20 kg); 1 tube (>20 kg)	PO	not captured	standing	pages 18, 19

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	10 mg	IM	not captured	standing	page 32
Obstetric hemorrhage	adult	10 mg	IV	not captured	standing	page 32
Obstetric hemorrhage	adult	20 unit	IV	not captured	standing	page 32

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1–2 g	IV/IO	not captured	standing	page 29

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Croup	peds	11.25 mg	NEB	not captured	standing	page 86

Risperidone

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2 mg	PO/ODT	not captured	standing	pages 21, 103

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	1 mEq/kg	IV/IO	not captured	standing	pages 78, 141
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	pages 78, 141
Hyperkalemia	adult	0.5–2 mEq/kg	IV	not captured	standing	page 142
Hyperkalemia	peds	0.5–2 mEq/kg	IV	not captured	standing	page 142
Other	adult	0.5–1 mEq/kg	IV/IO	not captured	standing	pages 38, 60, 61, 62
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 38, 60, 61, 62

Sodium Nitrite

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	10 mL	IV/IO	not captured	standing	page 38
Cyanide poisoning	peds	0.2 mL/kg	IV/IO	not captured	standing	page 38

Sodium Thiosulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	50 mL	IV/IO	not captured	standing	page 38
Cyanide poisoning	peds	5 mL	IV/IO	not captured	standing	page 38

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1–2 drop	TOP	not captured	standing	page 73

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	2 g	IV	not captured	standing	page 32
Other	adult	2 g	IV	not captured	standing	page 110
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	page 75
Trauma / hemorrhage	peds	15 mg/kg	IV	not captured	standing	page 75
Traumatic arrest	adult	2 g	IV	not captured	standing	page 83
Traumatic arrest	peds	15 mg/kg	IV	not captured	standing	page 83

Cite this

Massachusetts Office of Emergency Medical Services, United States EMS Protocol Census. 195 dose entries, effective 2026-09-01.

https://protoquiz.com/census/agencies/massachusetts-office-of-emergency-medical-services/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.